Changes in Circulating Lysyl Oxidase-Like-2 (LOXL2) Levels, HOMA, and Fibrosis after Sustained Virological Response by Direct Antiviral Therapy

Background: we aimed to assess the influence of metabolic syndrome on fibrosis regression (using liver-stiffness measurement (LSM) and serological scores) and the relationship with the expression of lysyl oxidase-like-2 as a potential goal of antifibrotic therapy. Methods: We included 271 patients t...

Descripción completa

Detalles Bibliográficos
Autores principales: Puente, Angela, Fortea, Jose Ignacio, Posadas, Miguel, Garcia Blanco, Agustin, Rasines, Laura, Cabezas, Joaquin, Arias Loste, Maria Teresa, Llerena, Susana, Iruzubieta, Paula, Fábrega, Emilio, Crespo, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723423/
https://www.ncbi.nlm.nih.gov/pubmed/31426495
http://dx.doi.org/10.3390/jcm8081242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723423/
https://www.ncbi.nlm.nih.gov/pubmed/31426495
http://dx.doi.org/10.3390/jcm8081242

Ejemplares similares